Drawing for URINE SALIVA BLOOD

USPTO serial 87574430

URINE SALIVA BLOOD

Reviewed by CopyMark Law Group

Reg. 5403727Status 701Registered
Filing date
Status date
Registration date
Feb 13, 2018
Examiner
SHANAHAN, PATRICK
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with URINE SALIVA BLOOD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplements; Dietary supplements for urinary healthACTIVEJan 1, 1997

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 16, 2024NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sep 16, 20248.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Sep 16, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 15, 2024ES8RTEAS SECTION 8 RECEIVED
Feb 7, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 13, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 13, 2018R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Jan 10, 2018PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 1, 2018ALIEASSIGNED TO LIE
Dec 18, 2017CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Dec 14, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Dec 13, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 24, 2017GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2017GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2017DOCKASSIGNED TO EXAMINER
Aug 24, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance